Merck & Co Inc $58.17

up +0.06


24/7/2014 11:50 AM  |  NYSE : MRK  
Industries : Drugs / Drug Manufacturers - Major
Get Trend Analysis Icon Get MRK Trend Analysis - it has outperformed the S&P 500 by 4%

Partner Headlines

  1. Facebook, Gilead Headline IBD 50's Top 5 Earnings

    IBD
  2. UnitedHealth Group Up on Weak Day for the Dow

    GuruFocus
  3. U.S. Markets Regain Losses from Last Week

    GuruFocus
  4. Abner Herrman Is Increasing Position in the Pharmaceutical Sector

    GuruFocus
  5. Senators Ask Gilead To Explain Sovaldi Pricing

    IBD
  6. Bristol-Myers Seeking Nivolumab Approval In Melanoma

    IBD
  7. Job or Invest: Growth Often Equals Happiness

    YCharts
  8. Markets Marginally Lower Ahead Of Earnings Season

    Benzinga
  9. Merck, Gilead Lead Race To Eradicate Hepatitis C

    IBD
  10. Exclusive: Enanta Pharmaceuticals CEO Jay Luly Discusses Hep C Pipeline

    Benzinga
  11. Markets Little Changed Ahead Of 4th Of July Break

    Benzinga
  12. Barclays Downgrades Pharmaceutical Sector

    Benzinga
  13. US Stock Futures Fall Ahead Of Home Sales Report

    Benzinga
  14. Exclusive: Hepatitis C Stock Valuation With Enanta CEO Jay Luly

    Benzinga
  15. Bristol-Myers Stock Up On Nivolumab Trial Success

    IBD
  16. Achillion

    IBD
  17. Dow, S&P 500 End At New Highs, Led By Auto Retailers

    IBD
  18. Achillion Could Win Idenix's Mystery Suitor: Analyst

    IBD
  19. Dow, S&P 500 Hit All-Time Highs As Volume Swells

    IBD
  20. 5-Star Biotech Stock Watch: Synta Pharmaceuticals

    Benzinga
  21. Stock Futures Hold Narrow Gains; Adobe Systems Up On Q2 Results

    IBD
  22. Allergan, Actavis Top Big Cap Pharmas Amid M&A Flurry

    IBD
  23. Achillion Gets Massive Price Target Hike On HCV Drugs

    IBD
  24. Achillion Gets Massive Price Target Hike On HCV Drugs

    IBD
  25. U.S. Equity Markets Continue to Hit New Highs

    GuruFocus
  26. UPDATE: Bank Of America Reiterates On Merck & Co. On Higher Sales Estimates

    Benzinga
  27. Feed Your Brain Daily: Read, Study, Mingle

    IBD
  28. Sovaldi and Drug Pricing: The United States of Saps

    YCharts
  29. FDA lifts hold, Achillion soars

    IBD
  30. ETF Outlook For Tuesday, June 10, 2014 (IAT, FXE, PBE, HYHG, IDIX, MRK)

    Benzinga
  31. Achillion Forges Ahead With Hep C Program On FDA OK

    IBD
  32. Merck Makes Big Hep C Buy

    IBD
  33. Benzinga's M&A Chatter for Monday June 9, 2014

    Benzinga
  34. Market Wrap For June 9: Markets Higher On St. Louis Fed Comments, Low Volume

    Benzinga
  35. Stocks Gain In Mixed Trade; Chips Soar, Keurig Caves

    IBD
  36. Mid-Afternoon Market Update; Icahn's 9% Stake In Family Dollar, Tyson Foods ...

    Benzinga
  37. Are Gilead Shares Overreacting To Merck's Idenix Acquisition?

    Benzinga
  38. Tyson's $8.5 Bil Hillshire Deal Tops Monday's M&As

    IBD
  39. Mid-Day Market Update: Idenix Pharma Surges On Merck Buyout; Pilgrim's ...

    Benzinga
  40. Merck Takes The 'Nuc' Option In Hepatitis C Race

    IBD
  41. Benzinga's Volume Movers

    Benzinga
  42. Stocks Hitting 52-Week Highs

    Benzinga
  43. Mid-Morning Market Update: Markets Edge Higher; Tyson Wins Bidding Battle ...

    Benzinga
  44. Morning Market Movers

    Benzinga
  45. Hepatitis C Stocks Move After Idenix Rockets Up 235%

    Benzinga
  46. Benzinga's Top #PreMarket Losers

    Benzinga
  47. Benzinga's Top #PreMarket Gainers

    Benzinga
  48. UPDATE: Merck Announces Will Purchase Idenix for $3.85Bn

    Benzinga
  49. Stocks Poised to Slip from Record Highs

    FoxBusiness
  50. Wall Street Turns Higher

    FoxBusiness
Trading Center